Big Move For Genprex, Inc.

Thu, Apr 03, 2025 at 08:03 PM

Genprex, Inc. (GNPX:NASDAQ) soared at $0.43, a gain of 46.3%. On Thu, Apr 03, 2025, GNPX:NASDAQ hit a New 2-Week High of $0.43. The stock appeared on our News Catalysts scanner on Thu, Apr 03, 2025 at 03:08 AM in the 'MISCELLANEOUS' category. From Thu, Mar 20, 2025, the stock recorded 40.00% Up Days and 54.55% Green Days

The stock spiked on Tue, Mar 18, 2025 at $0.52 with a volume of 44M+.

About Genprex, Inc. (GNPX:NASDAQ)

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.

Top 10 Gainers:

MEDIROM Healthcare Technologies Inc. (MRM:NASDAQ), 92.92%
Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
OSR Holdings Inc. (OSRH:NASDAQ), 68.03%
Alaunos Therapeutics Inc Com (TCRT:NASDAQ), 50.71%
Tivic Health Systems Inc. (TIVC:NASDAQ), 49.85%
Genprex, Inc. (GNPX:NASDAQ), 46.31%
Aptevo Therapeutics Inc. (APVO:NASDAQ), 44.2%
NeOnc Technologies Holdings Inc. (NTHI:NASDAQ), 36.86%
Local Bounti Corporation (LOCL:NYSE), 34.29%
Direxion Daily Semiconductor Bear 3X Shares (SOXS:NYSE), 29.8%